These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2653370)

  • 21. Homologies between cell interaction molecules controlled by major histocompatibility complex- and Igh-V-linked genes that T cells use for communication; both molecules undergo "adaptive" differentiation in the thymus.
    Yamauchi K; Flood PM; Singer A; Gershon RK
    Eur J Immunol; 1983 Apr; 13(4):285-91. PubMed ID: 6343093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conclusion: a simple, conservative model for antigen-specificity and MHC-restriction in lymphocyte communication.
    Eichmann K
    Springer Semin Immunopathol; 1980 Aug; 3(2):277-80. PubMed ID: 6168026
    [No Abstract]   [Full Text] [Related]  

  • 23. New concepts in autoimmunity.
    Zanetti M
    Immunol Invest; 1986 May; 15(3):287-310. PubMed ID: 3093374
    [No Abstract]   [Full Text] [Related]  

  • 24. The expression of a set of antibody variable regions in lipopolysaccharide-reactive B cells at various stages of ontogeny and its control by anti-idiotypic antibody.
    Nishikawa S; Takemori T; Rajewsky K
    Eur J Immunol; 1983 Apr; 13(4):318-25. PubMed ID: 6602052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics, expression, and function of idiotypes.
    Rajewsky K; Takemori T
    Annu Rev Immunol; 1983; 1():569-607. PubMed ID: 6399979
    [No Abstract]   [Full Text] [Related]  

  • 26. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-T cell interactions in cell-mediated immune responses to major histocompatibility complex antigens.
    Rich RR; Rich SS
    Crit Rev Immunol; 1983; 4(2):129-68. PubMed ID: 6221885
    [No Abstract]   [Full Text] [Related]  

  • 28. Clonogenic potential of murine CD4+8+ thymocytes. Direct demonstration using a V beta 6-specific proliferative stimulus in Mlsa mice.
    Howe RC; MacDonald HR
    J Immunol; 1989 Aug; 143(3):793-7. PubMed ID: 2526174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organization and expression of murine T cell receptor genes.
    Hashimoto Y
    Year Immunol; 1986; 2():237-44. PubMed ID: 3033945
    [No Abstract]   [Full Text] [Related]  

  • 30. The biochemistry of antigen-specific T-cell factors.
    Webb DR; Kapp JA; Pierce CW
    Annu Rev Immunol; 1983; 1():423-38. PubMed ID: 6085786
    [No Abstract]   [Full Text] [Related]  

  • 31. Rejection of allo-or xenografts of lymphoid cells by nude mice: T cell suicide as a result of cooperation between histoincompatible T and B cells.
    Piguet PF; Vassalli P
    J Immunol; 1978 Jan; 120(1):79-85. PubMed ID: 24074
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunology: development and modification of the lymphocyte repertoire.
    Gefter M; Marrack P
    Nature; 1986 May 8-14; 321(6066):116-8. PubMed ID: 3084977
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of a poly(LTyr,LGlu)-poly(DLAla)--poly(LLys)-specific helper factor derived from a T cell hybridoma.
    Apte RN; Eshhar Z; Löwy I; Zinger H; Mozes E
    Eur J Immunol; 1981 Nov; 11(11):931-6. PubMed ID: 6173232
    [No Abstract]   [Full Text] [Related]  

  • 34. Recognition of MOPC-460 variable region determinants by polyclonally distributed triggering receptors on B lymphocytes.
    Primi D; Juy D; Le Guern C; Sanchez P; Cazenave PA
    J Immunol; 1981 Oct; 127(4):1714-8. PubMed ID: 6168701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell interactions between histoincompatible T and B lymphocytes. V. Failure of histoincompatible T cells to interfere with physiologic cooperation between syngeneic T and B lymphocytes.
    Katz DH; Hamaoka T; Dorf ME; Benacerraf B
    J Immunol; 1974 Feb; 112(2):855-7. PubMed ID: 4130699
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthetic peptides and beta-chain gene rearrangements reveal a diversified T cell repertoire for a lambda light chain third hypervariable region.
    Bogen B; Snodgrass R; Briand JP; Hannestad K
    Eur J Immunol; 1986 Nov; 16(11):1379-84. PubMed ID: 3096741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of monoclonal anti-idiotypic antibodies for studying antigen-specific T and B cell receptors.
    Sommé G; Roth C; Bismuth G; Gougeon ML; Thèze J
    Dev Biol Stand; 1984; 57():385-91. PubMed ID: 6335440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. T-cell hybridoma bearing heavy chain variable region determinants producing (T,G)-A--L-specific helper factor.
    Eshhar Z; Apte RN; Löwy I; Ben-Neriah Y; Givol D; Mozes E
    Nature; 1980 Jul; 286(5770):270-2. PubMed ID: 6157102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The targeting of CD4+ T lymphocytes to a B cell lymphoma. A comparison of anti-CD3-anti-idiotype antibody conjugates and antigen-anti-idiotype antibody conjugates.
    Gravelle M; Ochi A
    J Immunol; 1989 Jun; 142(11):4079-84. PubMed ID: 2523940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice.
    Dembic Z; Hofgaard PO; Omholt H; Bogen B
    Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.